BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+8.83%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$3.57T
AUM Growth
+$193B
(+5.7%)
Cap. Flow
-$58.9B
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
18.35%
Holding
5,584
New
300
Increased
1,993
Reduced
2,724
Closed
121
Top Buys
| 1 |
Palantir
PLTR
|
+$1.05B |
| 2 |
Sea Limited
SE
|
+$771M |
| 3 |
Blackstone
BX
|
+$713M |
| 4 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$698M |
| 5 |
Wells Fargo
WFC
|
+$697M |
Top Sells
| 1 |
Alibaba
BABA
|
+$16.8B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$5.54B |
| 3 |
Apple
AAPL
|
+$3.6B |
| 4 |
Microsoft
MSFT
|
+$3.52B |
| 5 |
Linde
LIN
|
+$2.05B |
Sector Composition
| 1 | Technology | 22.69% |
| 2 | Healthcare | 13.59% |
| 3 | Financials | 13.13% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Communication Services | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3226
James Hardie Industries plc
JHX
$11.6B
| $20.5M | ﹤0.01% |
598,221
-4,668
| -0.8% | -$160K |
|
|
DSSI
3227
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $20.4M | ﹤0.01% |
2,053,010
+114,153
| +6% | +$1.14M |
|
|
HCAR
3228
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
| $20.4M | ﹤0.01% |
+2,112,000
| New | +$20.4M |
|
3229
Donegal Group Class A
DGICA
$711M
| $20.4M | ﹤0.01% |
1,402,815
+227,512
| +19% | +$3.31M |
|
3230
Athira Pharma
ATHA
$14.2M
| $20.4M | ﹤0.01% |
1,993,048
+1,002,599
| +101% | +$10.3M |
|
3231
ARKO Corp
ARKO
$567M
| $20.4M | ﹤0.01% |
2,217,580
+856,524
| +63% | +$7.87M |
|
3232
Apyx Medical
APYX
$79.4M
| $20.4M | ﹤0.01% |
1,974,248
-450,163
| -19% | -$4.64M |
|
3233
ACM Research
ACMR
$1.92B
| $20.3M | ﹤0.01% |
595,989
-2,456,934
| -80% | -$83.7M |
|
|
AMPE
3234
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $20.3M | ﹤0.01% |
40,469
+28,622
| +242% | +$14.3M |
|
3235
AquaBounty Technologies
AQB
$4.42M
| $20.2M | ﹤0.01% |
188,369
+119,934
| +175% | +$12.9M |
|
3236
Prelude Therapeutics
PRLD
$64M
| $20.1M | ﹤0.01% |
702,842
+21,117
| +3% | +$605K |
|
3237
Greif Class B
GEF.B
$2.46B
| $20.1M | ﹤0.01% |
339,888
+355
| +0.1% | +$20.9K |
|
3238
Spok Holdings
SPOK
$360M
| $20M | ﹤0.01% |
2,080,629
-1,004,552
| -33% | -$9.66M |
|
|
NIU
3239
Niu Technologies
NIU
$316M
| $20M | ﹤0.01% |
611,283
+16,051
| +3% | +$524K |
|
3240
Cytosorbents Corp
CTSO
$58.9M
| $19.9M | ﹤0.01% |
2,641,166
-187,436
| -7% | -$1.42M |
|
3241
XBiotech
XBIT
$83.8M
| $19.9M | ﹤0.01% |
1,201,597
-155,978
| -11% | -$2.58M |
|
3242
Mid Penn Bancorp
MPB
$691M
| $19.8M | ﹤0.01% |
722,624
+299,975
| +71% | +$8.23M |
|
|
SOHU
3243
Sohu.com
SOHU
$480M
| $19.8M | ﹤0.01% |
1,065,124
+84,881
| +9% | +$1.58M |
|
3244
iShares Core MSCI Europe ETF
IEUR
$6.92B
| $19.8M | ﹤0.01% |
345,565
-3,589
| -1% | -$206K |
|
3245
Investors Title Co
ITIC
$481M
| $19.8M | ﹤0.01% |
113,328
-3,552
| -3% | -$620K |
|
|
PRTK
3246
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $19.8M | ﹤0.01% |
2,897,320
-581,120
| -17% | -$3.96M |
|
3247
AbCellera Biologics
ABCL
$1.34B
| $19.7M | ﹤0.01% |
897,187
+41,714
| +5% | +$918K |
|
3248
KALA BIO
KALA
$131M
| $19.7M | ﹤0.01% |
74,463
+8,050
| +12% | +$2.13M |
|
3249
Amalgamated Financial
AMAL
$859M
| $19.7M | ﹤0.01% |
1,260,468
-46
| -0% | -$719 |
|
3250
Compugen
CGEN
$125M
| $19.7M | ﹤0.01% |
2,378,179
-37,490
| -2% | -$310K |
|